Anurekha Chadha, MD
Rheumatology · Austin, TXNPI 1548256845
Payments from drug & device makers
Across 379 payments — averaging $4939.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$392K
- Astrazeneca UK Limited$339K
- Pfizer$292K
- Janssen Research & Development, LLC$230K
- Amgen$184K
- UCB SA$173K
- plus $261K from 17 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 16 | $391,810 |
| Astrazeneca UK Limited | 13 | $339,142 |
| Pfizer | 28 | $292,070 |
| Janssen Research & Development, LLC | 52 | $230,442 |
| Amgen | 18 | $184,468 |
| UCB SA | 26 | $172,856 |
| GSK | 18 | $168,405 |
| Sanofi US Services Inc. | 9 | $45,983 |
| Bristol Myers Squibb | 8 | $34,158 |
| Sandoz | 1 | $5,224 |
| Sanofi Pasteur Inc. | 2 | $3,040 |
| Johnson & Johnson | 92 | $1,735 |
| AbbVie | 64 | $976 |
| Hexal AG | 1 | $663 |
| AstraZeneca | 9 | $328 |
| Eli Lilly | 2 | $326 |
| UCB, Inc. | 10 | $206 |
| Actelion Pharmaceuticals US, Inc. | 3 | $54 |
| Janssen Scientific Affairs, LLC | 2 | $38 |
| Genentech USA, Inc. | 2 | $35 |
| Lilly USA, LLC | 1 | $24 |
| Sobi, Inc | 1 | $19 |
| Novartis | 1 | $12 |
How this compares
$1,872,013 in reported general payments places this provider in the 95th percentile of 512 rheumatology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Austin
- Paul PickrellAustin$40.9M
- Tina BunchAustin$974K
- Atul SinghalMesquite$13.9M
- Shaikh AliTomball$9.8M
- Jitendra VasandaniLubbock$6.4M
- Dhiman BasuColleyville$6.2M
- Tamar BrionezThe Woodlands$5.2M
- Philip WallerHouston$4.9M
- John CushDallas$3.9M
- Sabeen NajamBaytown$3.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.